RICHARD MITTEER: Open Payments
NPI 1003370347 · CHESTER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$831 in 44 payments from 8 companies in 2025. Trend: 2023 $209 · 2024 $356 · 2025 $831
Food & beverage: $831
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 14 | $240 |
| ABBVIE INC. | 12 | $189 |
| Otsuka America Pharmaceutical, Inc. | 6 | $127 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $94 |
| Braeburn Inc. | 3 | $76 |
| Teva Pharmaceuticals USA, Inc. | 3 | $65 |
| Exact Sciences Corporation | 1 | $20 |
| Indivior Inc. | 1 | $20 |
Products named: REXULTI, VRAYLAR, CAPLYTA, MAVYRET, BRIXADI, AUSTEDO XR, Cologuard Collection Kit, SUBLOCADE.
Industry payments across PA — which companies pay providers there.
